Probe pin material including Ag—Pd—Cu-based alloy

    公开(公告)号:US11807925B2

    公开(公告)日:2023-11-07

    申请号:US17982092

    申请日:2022-11-07

    摘要: A probe pin material including a Ag—Pd—Cu-based alloy essentially including Ag, Pd and Cu, B as a first additive element, and at least any element of Zn, Bi and Sn, as a second additive element. A concentration of the first additive element is 0.1 mass % or more and 1.5 mass % or less, and a concentration of the second additive element is 0.1 mass % or more and 1.0 mass % or less. A Ag concentration, a Pd concentration and a Cu concentration in the Ag—Pd—Cu-based alloy are required as follows: a Ag concentration (SAg), a Pd concentration (SPd) and a Cu concentration (SCu) converted as given that a Ag—Pd—Cu ternary alloy is formed from only such three elements all fall within a predetermined range in a Ag—Pd—Cu ternary system phase diagram. The probe pin material is excellent in resistance value and hardness/wear resistance, and also is enhanced in bending resistance.

    Pt—Co based alloy for medical use

    公开(公告)号:US11795527B2

    公开(公告)日:2023-10-24

    申请号:US17295778

    申请日:2019-11-18

    IPC分类号: C22C19/07 A61L31/02

    CPC分类号: C22C19/07 A61L31/022

    摘要: The present invention relates to an alloy for medical use, including Pt, Co, Cr, Ni, and Mo. The alloy includes 10 atom % or more and 30 atom % or less of Pt, 20 atom % or more and 31 atom % or less of Cr, 5 atom % or more and 24 atom % or less of Ni, 4 atom % or more and 8 atom % or less of Mo, the balance Co, and unavoidable impurities, and a ratio of the Ni content (CNi) to the Pt content (CPt), CNi/CPt is 1.5 or less. The present invention can be applied to various kinds of devices for medical use, such as catheter, embolic coils, and guide wires, in addition to stents such as flow-diverter stents.

    Medical Pt-W alloy
    5.
    发明授权

    公开(公告)号:US11795524B2

    公开(公告)日:2023-10-24

    申请号:US17940965

    申请日:2022-09-08

    IPC分类号: C22C5/04 A61L31/02 A61L31/14

    摘要: The present invention relates to a medical Pt—W alloy, containing 10 mass % or more and 15 mass % or less of W, with the balance being Pt and inevitable impurities, in which a Zr content is 1000 ppm or less. Limiting the Zr content can improve workability, particularly workability at the stage of hot working. Regarding impurity control, further limiting a Ca content to 250 ppm or less can provide more suitable workability. The present invention is good in workability in processing into a wire included in an embolic coil, a guide wire or the like.

    FE-PT-BN-BASED SPUTTERING TARGET AND METHOD FOR MANUFACTURING SAME

    公开(公告)号:US20220356557A1

    公开(公告)日:2022-11-10

    申请号:US17623511

    申请日:2020-04-07

    IPC分类号: C23C14/34 C22C38/00 C22C33/02

    摘要: Provided is an Fe—Pt—BN-based sputtering target that has a high relative density and that suppresses particle generation.
    The Fe—Pt—BN-based sputtering target has, as a residue after dissolution in aqua regia measured by a procedure below, the particle size distribution in which D90 is 5.5 μm or less and a proportion of fine particles smaller than 1 μm is 35% or less. The procedure includes: (1) cutting out an about 4 mm-square sample piece from the sputtering target, followed by pulverizing to prepare a pulverized product; (2) classifying the pulverized product using sieves of 106 μm and 300 μm in opening size and collecting a powder that has passed through the 300 μm sieve and remained on the 106 μm sieve; (3) immersing the powder in aqua regia heated to 200° C. to prepare a residue-containing solution in which the powder has been dissolved; (4) filtering the residue-containing solution through a 5A filter paper specified in JIS P 3801 and drying a residue on the filter paper at 80° C. to prepare a residue powder; (5) dispersing the residue powder in water containing a surfactant to prepare a sample solution; and (6) setting the sample solution in a particle size analyzer and measuring the particle size distribution.